Recombinant T-cell receptors from HPA-1a specific T-cells
Fetal- and neonatal alloimmune thrombocytopenia is a condition that can cause hemorrhage and potential brain damage or death in neonates. It is most often a result of maternal alloantibodies specific for fetal Human Platelet antigen 1a (HPA-1a) that destroy fetal platelets. The recognition of the HPA-1a peptide-MHC complex by T-cells involve a peculiar form of T-cell receptor peptide-MHC interaction in which the Leu33 residue is essential for T-cell stimulation, not by being directly presented to the TCR, but by acting as an anchor residue and increasing peptide binding and stability of the peptide-MHC complex, compared to the Pro33 allovariant. Studies of immunized women have been found to involve a diverse set of T-cells with varying responsiveness. To build a solid platform in which to study the peptide-MHC interactions involved in this condition, the goal of this project was to attempt to produce soluble, recombinant T-cell receptors from an HPA-1a-specific T cell line (D7T4) characterized from an alloimmunized woman. Through cloning and recombination of D7T4-TCRα and D7T4-TCRβ plasmids and vectors used in multigene baculoviral vectors, and their fusion, baculovirus vectors for transfection and expression of D7T4-TCRαβ in insect cells were produced. D7T4-TCRαβ was found to be expressed in its expected dimeric form in insect cells, but its functionality as a T-cell receptor was not clearly demonstrated.
PublisherUiT Norges arktiske universitet
UiT The Arctic University of Norway
MetadataShow full item record
Copyright 2022 The Author(s)
The following license file are associated with this item: